Science Market Update

UC Davis School of Medicine in Top 20% for NIH Research Funding

Posted by Gloria Beverage on Fri, Jun 01, 2018

UC Davis School of Medicine in Sacramento ranked in the top 20 percent of national medical schools for research funding by the National Institute of Health (NIH). According to the 2017 report issued by the Blue Ridge Institute for Medical Researchthe school received $176 million to fund 356 grant proposals last year. This placed UC Davis at 26th in the nation for NIH funding.

 

 

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, 2018, nih research funding, NIH awards 2017, NIH funding, Research Funding

UC Davis Receives $2.5 Million Cancer Research Grant

Posted by BCI Staff on Fri, May 18, 2018

Last Fall, UC Davis' Comprehensive Cancer Center  received its first National Cancer Institute (NCI) Moonshot Grant of $2.5 million to research two types of cancers in dogs that are very similar to cancer in humans. 

UC Davis boasts both a world renowned veterinary school and medical school. Researchers are equipped with the tools to examine the link between cancer in dogs and cancer in humans. UC Davis has a Comparative Oncology Program at the Comprehensive Cancer Center, one of very few in the nation.

The program allows for veterinarians and physicians to work together to find creative cancer solutions. Robert Canter, a surgical oncologist at the Davis Comprehensive Cancer Center, and Robert Rehun, a veterinary oncologist, plan to conduct various research trials with the Moonshot Grant.

The trials will be focused on isolating dogs' natural killer cells. Killer cells are white blood cells that are particulary good at eliminating cells infected with viruses or cancer cells. Once the killer cells are isolated, researchers hope to connect the killer cells with human IL15. IL15 is a cytokine that might help activate the killer cells in human patients. 

This study is just one example of the many different projects that UC Davis facilitates to help advance cancer research. This past year, the Davis Comprehensive Cancer Center received $7.3 million in support. The Biomedical Technology Program at the Cancer Center alone has over 20 active projects and almost $24 million in funding.

 

Read More

Tags: CA, University of California Davis Medical Center, Southwest, UCDMC, BioResearch Product Faire Event, Sacramento, 2018, Oncology, Cancer Immunotherapy

Two UCSD Life Science Researchers Awarded $3 Million Breakthrough Prize

Posted by Rebecca Inch-Partridge on Fri, Jan 12, 2018

UC San Diego life science researchers Don Cleveland and Joanne Chory were awarded 2018 Breakthrough Prize awards in December. Each winner receives $3,000,000, which makes the Breakthrough Prize among science’s largest award. The Breakthrough Prize is intended to highlight scientists who are tackling the biggest questions and toughest challenges in order to improve lives.

Dr. Cleveland, distinguished professor of cellular and molecular medicine, neurosciences and medicine at UC San Diego School of Medicine, was honored for his research of inherited neurodegenerative diseases such as ALS and Huntington’s. (Image courtesy of UCSD)

Dr. Chory, a plant biologist at Salk Institute and an adjunct professor in the Division of Biological Sciences at UC San Diego received her honors “for discovering how plants optimize their growth, development, and cellular structure to transform sunlight into chemical energy.” 

Read More

Tags: 2018, SDVS, Biotechnology Vendor Showcase, UCSD, CA, San Diego, life sciecne, San diego Biotech, University of California San Diego, san diego research, Research Funding, laboratory equipment suppliers, Bioresearch product fair

UCSD Scientists Receive $8M to Research Leukemia Treatments

Posted by Laura Braden on Tue, Jan 02, 2018

Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)

Read More

Tags: 2018, SDVS, Biotechnology Vendor Showcase, UCSD, cancer research, cancer research funding, new research funding, Leukemia, Acute Myeloid Leukemia, AML Research, CA, San Diego

USC Receives $19M for BRAIN Initiative Study

Posted by Laura Braden on Thu, Nov 30, 2017

In 2013, president Barack Obama initiated a public-private partnership - the BRAIN Initiative - to provide more funding and opportunities for institutions and organizations to study the human brain. This project is led by the National Institutes of Health and includes a new five-year collaborative project, the BRAIN Initiative Cell Census Network consortium that is aiming to identify all cells in a mouse brain to create a catalog of these cells.

Read More

Tags: 2018, USC, University of Southern California, NIH award, brain cell research, BRAIN Initiative, BioResearch Product Faire Event, CA

UC Davis Researchers Receive $1.5M to Study Immune Cells for Tumor Treatment

Posted by Laura Braden on Mon, Nov 06, 2017

White blood cells help the immune system protect the body from infections and diseases. Along with attacking infections, white blood cells also have the ability to bring other cells together to help in the fight. With these known abilities of white blood cells, life science researchers have been researching ways to amplify the abilities of these cells to target specific illnesses, such as tumors. 

Read More

Tags: 2018, UCDMC, University of California Davis Medical Center, University of California Davis, Sacramento, CA, NIH funding, Cancer Treatment, Immune System

UCSD Scientists Fight Brain Cancer with the Zika Virus

Posted by Laura Braden on Thu, Oct 26, 2017

Like most forms of cancer, brain cancers are frequently treated with chemotherapy and radiation therapy. Although these treatments can be effective, many times they are not. Scientists around the world study different types of brain cancers to develop new treatment methods. 

Read More

Tags: SDVS, UCSD, University of California San Diego, Biotechnology Vendor Showcase Event, 2018, CA, Zika virus, Brain cancer, cancer research

$8 M in Research Funding to Expand Stem Cell Trials at UC Davis

Posted by Rebecca Inch-Partridge on Mon, Oct 16, 2017

UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.

Read More

Tags: UCD, UC Davis - Medical Center, Research Funding, Bioresearch Grant, BioResearch Product Faire, California, CA, Southwest Region, research grant, new research grant, laboratory equipment, laboratory equipment suppliers, Lab Supply, Current Biotechnology Events, Laboratory product sales, Stem cell research, Human Stem Cell, immunotherapy, laboratory tools

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: 2017, UCLA, new research funding, NIH funding, LAVS, Biotechnology Vendor Showcase, CA, cytomegalovirus

USC Researchers Use Proteins to Boost Immune System in Fighting HIV

Posted by Laura Braden on Mon, Oct 02, 2017

According to the World Health Organization, more than 36.7 million people around the world are infected with Human Immunodeficiency Virus (HIV). Although there is not yet a cure for HIV, some treatments are able to slow the spread of the virus. Researchers around the world study the virus with the hope of one day creating a cure to attack the virus. A team of researchers from the University of Southern California in Los Angeles are taking a different approach to fighting HIV - by creating a treatment that boosts the immune system instead of attacking the virus.

Read More

Tags: USC, University of Southern California, 2018, BioResearch Product Faire Event, HIV research, CA, Los Angeles, HIV treatment

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News